Form 4 for ABT Abbott Laboratories
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-17 · accession 0001415889-21-006161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-12-17 | ABT | Wainer Andrea F | EVP | M - OptEx | $47.00 | +7,500 | 57.3K | +15% | +$352.5K |
| D | 2021-12-21 | 2021-12-17 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $137.54 | -7,500 | 49.8K | -13% | -$1.03M |
| D | 2021-12-21 | 2021-12-17 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -7,500 | 14.2K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-12-17 | M | A | 7,500 | $47.00 | 57,282 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-12-17 | S | D | 7,500 | $137.54 | 49,782 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-12-17 | M | D | 7,500 | $0.00 | 14,226 | D | $47.00 · 2018-02-20 to 2025-02-19 | 7,500 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |